The effect of a promoter (calcium) and an inhibitior (magnesium) of urolithiasis was spectrophotometrically studied on urokinase (0.45 IU) and sialidase (5 mM). Although these mineral did not affect the sialidase activity, total inhibition of urokinase activity was observed with either 0.05 M calcium chloride or 0.1 M magnesium chloride. This observation might explain why calcium and magnesium respectively function as a promoter and an inhibitor of stone formation.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Aswegen CH van, Neitz AHW, Becker PJ, Plessis DJ du (1988) Renal calculi-urate as a urokinase inhibitor. Urol Res 16: 143
Aswegen CH van, Hurter P, Merwe CA van der, Plessis DJ du (1989) The relationship between total urinary testosterone and renal calculi. Urol Res 17: 181
Aswegen CH van, Merwe CA van der, Plessis DJ du (1990) Sialic acid concentrations in urine of men with and without renal stones. Urol Res 18: 29
Backman U, Danielson BoG, Ljunghall S (1985) Renal stones: etiology, management, treatment. Almquist and Wiksell, Stockholm, Sweden, p 16
Baggio B, Gambaro G, Favaro S, Borsatti A, Pavenello Siviero B, Zacchello G, Rizzoni GF (1983) Juvenile renal stone disease: a study of urinary promoting and inhibiting factors. J Urol 130: 1133
Barlow GH (1976) Urinary and kidney cell plasminogen activator (urokinase). In: Lorand L (ed) Methods in enzymology, sect III, chapt 20. Academic Press, New York, p 239
Boyce WH, Swanson M (1955) Biocolloids in urine in health and in calculous disease. II. Electrophoretic and biochemical studies of a mycoprotein insoluble in molar sodium chloride. J Clin 34: 1581
Cs-Szàbo G, Pozsgay M, Elödi P (1980) Investigation of the substrate-binding site of human plasmin using tripeptisyl-p-nitroanalide substrate. Thromb Res 20: 199
Danielson BoG (1985) Renal stones-current viewpoints on etiology and management. Scand J Nephrol 19: 1
Hallson PC, Rose GA, Sulaiman S (1982) Magnesium reduce calcium oxalate crystal formation in human whole urine. Clin Sci 6: 17
Hayashi S, Yamada K (1981) Assay of urokinase activity plasma with a chromogenic substrate. Thromb Res 22: 573
Kitamura T, Zerwekh JE, Pak CYC (1982) Partial biochemical and physiochemical characterization of organic macromolecules in urine from patients with renal stones and control subjects. Kidney Int 21: 379
Lewis A, Schartz RH, Schenk EA (1971) Tamm-Horsfall mucoprotein. 1. Localization in the kidney. Lab Invest 25: 92
Nieuwenhuizen W, Wijngaards G, Groeneveld E (1977) Synthetic substrates and the discrimination between urokinase and tissue plasminogen activator activity. Thromb Res 11: 87
Nikkilä M, Koivula T, Jokela H (1989) Urinary excretion in patients with urolithiasis and normal subjects. Eur Urol 16: 382
Toki N, Sumi H (1982) Urinary trypsin inhibitors and urokinase activators in renal diseases. Acta Haematol (Basel) 67: 109
Wachsmuth ED, Fritze I, Pfleiderer G (1966) An aminopeptidase occurring in pig kidney. I. An improved method of preparation. Physical and enzymic properties. Biochemistry 5: 169
Wiman B, Malbring G, Ranhy M (1983) Plasminogen activator releas during venous stasis and exercise as determined by new specific assay. Clin Chim Acta 127: 279
Zimmerman M, Quigley JP, Ashe B, Dorn C, Goldfarb R, Troll W (1978) Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles. Proc Natl Acad Sci USA 75: 750
About this article
Cite this article
van Aswegen, C.H., Dirksen van Sckalckwyk, J.C., du Toit, P.J. et al. The effect of calcium and magnesium ions on urinary urokinase and sialidase activity. Urol. Res. 20, 41–44 (1992). https://doi.org/10.1007/BF00294333
- Kidney stones